The brokers need to factor this information into their valuation of the stock. It's an open playing field now, VLA is a definite target. To my knowledge, NSCLC treatment with Optivo was a lot of what the drug valuation was being based on!
VLA Price at posting:
96.0¢ Sentiment: Buy Disclosure: Held